glutathione transferase S-transferase: A versatile and dynamic enzyme Glutathione S-transferase and MRP1 form

The REDEFINE 1 trial found that treatment with CagriSema resulted in greater weight loss of 22.7% at 68 weeks versus 2.3% in the placebo group if all patients adhered to treatment.1* When evaluating the treatment effect regardless of adherence, those treated with CagriSema achieved statistically significant weight loss of 20.4% at 68 weeks versus 3.0% for the placebo group.1** In addition, a supportive secondary analysis showed that half (50.7%) of trial participants with obesity treated with CagriSema reached the threshold for non-obesity (BMI 5% (83.6% vs

Current research areas include: Nerve regeneration studies Gene therapy investigations New medication development Stem cell research Novel treatment approaches Bioengineered nerve grafts Managing Daily Life with Neuropathy Effective management of peripheral neuropathy involves a comprehensive approach to daily activities and lifestyle choices

Inflammation studies also examine immune-driven processes beyond tissue structure

Spreading redness, fever, lasting numbness or weakness are not normal and need medical attention